title: Regional and developmental variations of GFAP and actin mRNA levels in the CNS of jimpy and shiverer mutant mice.
abstract: Gliosis is a common reaction to brain damage. Glial fibrillary acidic protein (GFAP) is a classical astrocytic marker. We have undertaken to measure the level of GFAP-mRNA as an index of gliosis in the brain of jimpy (jp) and shiverer (shi) murine mutants, in which hypomyelination is either severe or moderate, respectively. This study was conducted in five different CNS regions and at different ages. In young jp mutant, the amount of GFAP-mRNA was either normal or lower than in control animals; but after 3 wk of age, the level of GFAP-transcript increased dramatically in all regions examined. A parallel increase in actin-mRNA was also observed, mostly in the diencephalon and to a lesser extent in cortex and spinal cord, but not in the cerebellum and brainstem. In the shi mutant, variations in the amount of GFAP-mRNA were less important than in the jp with two exceptions: In brainstem of 3-wk-old animals, a 2.5-fold increase was observed, and in all the regions but the spinal cord of 12-d-old shi, the levels of GFAP-transcript were 2-5 times lower than in controls. In this mutant, the levels of actin message were usually close to normal, or slightly lower than in controls.
authors.affiliation: Laboratoire de Neurobiologie cellulaire, moléculaire et clinique, INSERM U-134, Hôpital de la Salpêtrière, Université P. et M. Curie, Paris, France.
authors.forename: H
authors.initials: H
authors.lastname: Chen
authors.forename: F
authors.initials: F
authors.lastname: Cabon
authors.forename: P
authors.initials: P
authors.lastname: Sun
authors.forename: E
authors.initials: E
authors.lastname: Parmantier
authors.forename: P
authors.initials: P
authors.lastname: Dupouey
authors.forename: C
authors.initials: C
authors.lastname: Jacque
authors.forename: B
authors.initials: B
authors.lastname: Zalc
mesh_terms: D000199:Actins / Q000032:analysis*; D000367:Age Factors; D000818:Animals; D001253:Astrocytes / Q000737:chemistry / Q000473:pathology; D015415:Biomarkers / Q000032:analysis; D015152:Blotting, Northern; D001923:Brain Chemistry; D003711:Demyelinating Diseases / Q000378:metabolism* / Q000473:pathology; D005260:Female; D005904:Glial Fibrillary Acidic Protein / Q000032:analysis*; D005911:Gliosis / Q000378:metabolism*; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D008816:Mice, Jimpy / Q000378:metabolism*; D008818:Mice, Neurologic Mutants / Q000378:metabolism*; D009928:Organ Specificity; D012333:RNA, Messenger / Q000032:analysis*; D013045:Species Specificity; D013116:Spinal Cord / Q000737:chemistry* / Q000473:pathology
chemical_list: D000199:Actins; D015415:Biomarkers; D005904:Glial Fibrillary Acidic Protein; D012333:RNA, Messenger